You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FT-001

Showing 1 - 25 of 1,047
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biallelic RPE65 Mutation-associated Retinal Dystrophy Trial in Beijing (FT-001 Low Dose, FT-001 Mid Dose, FT-001 High Dose)

Recruiting
  • Biallelic RPE65 Mutation-associated Retinal Dystrophy
  • FT-001 Low Dose
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 11, 2023

Melanoma Trial in Worldwide (Nivolumab, Relatlimab)

Recruiting
  • Melanoma
  • Phoenix, Arizona
  • +84 more
Jan 31, 2023

Altitude Hypoxia Trial (Hypoxic breathing conditions)

Not yet recruiting
  • Altitude Hypoxia
  • Hypoxic breathing conditions
  • (no location specified)
May 10, 2023

Interlaminar Epidural Steroid Injections?

Recruiting
  • Cervical Disc Herniation
  • +2 more
  • Interlaminar Epidural Steroid Injection
  • Istanbul, Pendik, Turkey
    Marmara University Pendik Training and Research Hospital
Nov 25, 2022

Diabetic Macular Edema Trial in Tianjin (FT-003)

Recruiting
  • Diabetic Macular Edema
  • FT-003
  • Tianjin, Tianjin,China, China
    Tianjin Medical University Eye Hospital
Jun 14, 2023

Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients Trial in Assiut (Radioactive Iodine therapy)

Recruiting
  • Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients
  • Radioactive Iodine therapy
  • Assiut, Egypt
    Nuclear medicine unit, department of clinical oncology and nucle
Dec 8, 2022

Hearing Screener Trial in Wake Forest

Recruiting
  • Hearing Screener
    • Wake Forest, North Carolina
      Crossover Mangement
    Apr 28, 2023

    Neovascular Age-related Macular Degeneration Trial (FT-003)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • FT-003
    • (no location specified)
    Nov 21, 2022

    Fetal Monitoring Trial in Genk (Bloomlife Lovelace FT)

    Recruiting
    • Fetal Monitoring
    • Bloomlife Lovelace FT
    • Genk, Limburg, Belgium
      Ziekenhuis Oost-Limburg
    Dec 13, 2022

    Type 1 Diabetes Trial in Houston (Family Teamwork-Peer Delivery)

    Completed
    • Type 1 Diabetes
    • Family Teamwork-Peer Delivery
    • Houston, Texas
      Texas Children's Hospital
    Jul 22, 2022

    Asthma Trial (XKH001 Injection, XKH001 Placebo Injection)

    Not yet recruiting
    • Asthma
    • XKH001 Injection
    • XKH001 Placebo Injection
    • (no location specified)
    Aug 13, 2023

    Cognition Trial in Xi'an

    Active, not recruiting
    • Cognition
      • Xi'an, Shaanxi, China
        Fourth Military Medical University
      Jan 28, 2023

      Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

      Recruiting
      • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
      • Ocala, Florida
      • +3 more
      Jan 30, 2023

      Metastatic Castration-resistant Prostate Cancer Trial in United States (FT-7051)

      Recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • Scottsdale, Arizona
      • +7 more
      May 12, 2022

      Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • FT-2102 (olutasidenib)
      • +2 more
      • Los Angeles, California
      • +59 more
      Mar 2, 2022

      Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

      Completed
      • Safety
      • +2 more
      • RHN-001 (one tablet 750mg)
      • RHN-001 (750mg * 2 Tablets)
      • Karachi, Sindh, Pakistan
        Center for Bioequivalence Studies and clinical research (CBSCR),
      Apr 26, 2023

      Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

      Not yet recruiting
      • Acneiform Eruption Due to Chemical
      • +2 more
      • HT-001 2% Topical Gel
      • +3 more
      • (no location specified)
      Dec 3, 2022

      PRO for Fighting FT in Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • Questionnaires
      • Naples, Italy
        Nation Cancer Institute of Naples, Division of Medical Oncology
      Sep 13, 2023

      Ovarian Cancer, Fallopian Tube Adenocarcinoma, Primary Peritoneal Cavity Cancer Trial in Minneapolis (IP FT516, Enoblituzumab,

      Completed
      • Ovarian Cancer
      • +2 more
      • IP FT516
      • +2 more
      • Minneapolis, Minnesota
        University of Minnesota, Masonic Cancer Center
      Apr 12, 2022

      Pulmonary Embolism Trial in Louisville, Tulsa (FlowTriever2 Catheter)

      Enrolling by invitation
      • Pulmonary Embolism
      • FlowTriever2 Catheter
      • Louisville, Kentucky
      • +1 more
      Jan 19, 2023

      Urinary Tract Infections Trial in Doorn, Utrecht (Fosfomycin, Nitrofurantoin)

      Terminated
      • Urinary Tract Infections
      • Doorn, Utrecht, Netherlands
      • +3 more
      Feb 27, 2022

      Advanced Solid Tumor Trial in Shanghai (B4T2-001 autologous CAR-T)

      Recruiting
      • Advanced Solid Tumor
      • B4T2-001 autologous CAR-T
      • Shanghai, China/Shanghai, China
      • +1 more
      Oct 3, 2023

      l Gene Editing Therapy for Cardiovascular Disease

      Not yet recruiting
      • Atherosclerotic Cardiovascular Disease
      • +2 more
        • Auckland, New Zealand
        • +2 more
        Oct 31, 2023

        Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

        Completed
        • Solid Tumor, Adult
        • Minneapolis, Minnesota
        • +2 more
        Jan 27, 2023

        Non-Hodgkin Lymphoma Trial (CC-122, Dexamethasone)

        Not yet recruiting
        • Non-Hodgkin Lymphoma
        • (no location specified)
        Jan 10, 2023